137 related articles for article (PubMed ID: 6168426)
41. The treatment of advanced hodgkin's disease.
Straus DJ; Lee BJ; Koziner B; Nisce LZ; Young CW; Clarkson BD
Blut; 1981 Aug; 43(2):119-24. PubMed ID: 6167303
[TBL] [Abstract][Full Text] [Related]
42. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial.
Hutchinson RJ; Fryer CJ; Davis PC; Nachman J; Krailo MD; O'Brien RT; Collins RD; Whalen T; Reardon D; Trigg ME; Gilchrist GS
J Clin Oncol; 1998 Mar; 16(3):897-906. PubMed ID: 9508171
[TBL] [Abstract][Full Text] [Related]
43. CCNU, etoposide, and prednimustine (CEP) in refractory Hodgkin's disease.
Santoro A; Viviani S; Valagussa P; Bonfante V; Bonadonna G
Semin Oncol; 1986 Mar; 13(1 Suppl 1):23-6. PubMed ID: 2420012
[TBL] [Abstract][Full Text] [Related]
44. Prolonged disease-free survival in Hodgkin's disease with MOPP reinduction after first relapse.
Fisher RI; DeVita VT; Hubbard SP; Simon R; Young RC
Ann Intern Med; 1979 May; 90(5):761-3. PubMed ID: 434676
[TBL] [Abstract][Full Text] [Related]
45. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
46. Long-term follow-up with ABDIC salvage chemotherapy of MOPP-resistant Hodgkin's disease.
Tannir N; Hagemeister F; Velasquez W; Cabanillas F
J Clin Oncol; 1983 Jul; 1(7):432-9. PubMed ID: 6199478
[TBL] [Abstract][Full Text] [Related]
47. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)].
Zelechowska JA; Madej G; Piemkowska F
Nowotwory; 1976; 26(3):163-70. PubMed ID: 980801
[No Abstract] [Full Text] [Related]
48. [Results with MOPP combination chemotherapy in Hodgkin's disease (author's transl)].
Neumann E
Wien Klin Wochenschr; 1981 Feb; 93(4):134-7. PubMed ID: 6895134
[TBL] [Abstract][Full Text] [Related]
49. Comparison of two non-cross-resistant combinations (ABVP/LOPP) with COPP plus bleomycin in the treatment of advanced Hodgkin's disease.
Koza I; Bohunický L; Mociková K; Gyárfás J; Svancárová L; Mardiak J; Spánik S; Fuchsberger P; Thalmeinerová Z; Sufliarsky J
Neoplasma; 1991; 38(6):583-93. PubMed ID: 1722564
[TBL] [Abstract][Full Text] [Related]
50. Treatment of MOPP-refractory Hodgkin's disease with vinblastine, doxorubicin, bleomycin, CCNU, and dacarbazine.
Einhorn LH; Williams SD; Stevens EE; Bond WH; Chenoweth L
Cancer; 1983 Apr; 51(8):1348-52. PubMed ID: 6186356
[TBL] [Abstract][Full Text] [Related]
51. Combination chemotherapy of Hodgkin's disease in children.
Kolygin BA
Cancer; 1976 Oct; 38(4):1494-7. PubMed ID: 991072
[TBL] [Abstract][Full Text] [Related]
52. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
Lopez M
Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
[No Abstract] [Full Text] [Related]
53. [81 cases of Hodgkin's disease treated with extensive radiotherapy, including 65 with primary MOPP chemiotherapy (author's transl)].
Baillet F; Brun B; Maylin C; Mazeron JJ; Pierquin B; Dreyfus B
J Radiol Electrol Med Nucl; 1977 May; 58(5):343-6. PubMed ID: 886528
[TBL] [Abstract][Full Text] [Related]
54. Advanced Hodgkin disease with large mediastinal involvement can be treated with eight cycles of chemotherapy alone after a major response to six cycles of chemotherapy: a study of 82 patients from the Groupes d'Etudes des Lymphomes de l'Adulte H89 trial.
Brice P; Colin P; Berger F; de Kerviler E; Diviné M; Bouaffia F; Kerneis Y; Blanc M; Lepage E; Fermé C;
Cancer; 2001 Aug; 92(3):453-9. PubMed ID: 11505388
[TBL] [Abstract][Full Text] [Related]
55. Current approaches to the treatment of advanced-stage Hodgkin's disease.
Rusthoven JJ
CMAJ; 1986 Sep; 135(5):465-73. PubMed ID: 2427176
[TBL] [Abstract][Full Text] [Related]
56. Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.
Longo DL; Glatstein E; Duffey PL; Young RC; Hubbard SM; Urba WJ; Wesley MN; Raubitschek A; Jaffe ES; Wiernik PH
J Clin Oncol; 1991 Jun; 9(6):906-17. PubMed ID: 2033427
[TBL] [Abstract][Full Text] [Related]
57. [Comments about use of polychemotherapy MOPP associated with radiotherapy in the treatment of early stages of Hodgkin's disease. Preliminary report of 58 patients (author's transl)].
Brun B; Alaoui Y; Kuentz M; Baillet F; Maylin C; Vernant JP; Reyes F; Rochant H; Pierquin B; Dreyfus B
Ann Med Interne (Paris); 1980; 131(4):239-43. PubMed ID: 7425449
[TBL] [Abstract][Full Text] [Related]
58. Hodgkin's disease in renal transplant recipients.
Doyle TJ; Venkatachalam KK; Maeda K; Saeed SM; Tilchen EJ
Cancer; 1983 Jan; 51(2):245-7. PubMed ID: 6185199
[TBL] [Abstract][Full Text] [Related]
59. Combined chemotherapy (MOPP or ABVD)-radiotherapy approach in advanced Hodgkin's disease.
Bonadonna G; Zucali R; De Lena M; Valagussa P
Cancer Treat Rep; 1977 Aug; 61(5):769-77. PubMed ID: 70270
[No Abstract] [Full Text] [Related]
60. Treatment of advanced Hodgkin's disease: 10-year experience in the Eastern Cooperative Oncology group.
Glick JH; Barnes JM; Bakemeier RF; Prosnitz LR; Bennett JM; Neiman RS; Costello W; Orlow EL
Cancer Treat Rep; 1982 Apr; 66(4):855-70. PubMed ID: 7042087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
